ePlus Named Opengear’s Partner of the Year in North America
Mar 07, 2017 13:30 pm UTC| Business
HERNDON, Va., March 07, 2017 -- ePlus inc. (NASDAQ:PLUS) today announced that it has been selected as Partner of the Year in North America by Opengear, a leading provider of critical infrastructure management solutions....
Calix AXOS E9-2 Honored by 2017 Lightwave Innovation Reviews Program
Mar 07, 2017 13:25 pm UTC| Business
PETALUMA, Calif., March 07, 2017 -- Calix, Inc. (NYSE:CALX), the world leader in Subscriber Driven Intelligent Access, today announced that the AXOS E9-2 Intelligent Edge System was recognized by the 2017 Lightwave...
H.B. Fuller Announces Synthetic Polymers Price Increase Sold in North America
Mar 07, 2017 13:15 pm UTC| Business
ST. PAUL, Minn., March 07, 2017 -- H.B. Fuller Company (NYSE:FUL) announced today that, effective April 3, or as contracts allow, the North America Polymer group of H.B Fuller will increase the price for all emulsion...
Endeavour Posts Record 2016 Results
Mar 07, 2017 13:14 pm UTC| Business
ENDEAVOUR POSTS RECORD 2016 RESULTS Production up 13% · AISC down to record low $884/oz · Cash flow generation up 55% Q4 AND FY-2016 HIGHLIGHTS Record Q4-2016 performance with production of 175koz,...
Dean Factor, Founder and Creator of Smashbox Cosmetics, to Bring STROKE of BEAUTY to Evine
Mar 07, 2017 13:03 pm UTC| Business
Dean Factor and renowned makeup artist and painter Holly Mordini aim to inspire women on March 10 with their line of innovative color products ...
Nuvectra™ Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 07, 2017 13:02 pm UTC| Business
PLANO, Texas, March 07, 2017 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the fourth quarter and full year ended December 30, 2016. Recent...
Auris Medical to Announce Full Year 2016 Financial Results and Host Conference Call on March 14
Mar 07, 2017 13:02 pm UTC| Business
Zug, Switzerland, March 7, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it...